This page includes the latest news, press releases and information from ABC2. Annual Award Process ABC2 is presently accepting research proposals for the 2006 Project Awards. If you are interested in submitting an application, please see the RFA and details on the Award Process page. ADVANCE Newsletter Vol.1, No.1, 2003 - Kinase inhibitor therapy for brain cancer Vol.1, No.2, 2004 - Outwitting vascular barriers to effective drug delivery Vol.2, No. 1, 2005 - Direct Delivery of Innovative Drugs to Treat Brain Cancer Press Coverage November 10, 2005 -- Dr. Paul Mischel, a UCLA associate professor of pathology and laboratory medicine and a four-time ABC2 award recipient, has a recent article, Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors published in the November 10, 2005 issue of the New England Journal of Medicine. May 30, 2005 -- BioCentury article on: Venture Philanthropy General News June 29, 2006 -- Accelerate Brain Cancer Cure (ABC2) and the Tug McGraw Foundation Unite to Address Quality of Life for Patients with Brain Cancer January 10, 2006 -- Chairman Steve Case made a presentation to the January 10, 2006 JPMorgan Healthcare Conference in San Francisco January 10, 2006 -- Kate Carr to Lead Accelerate Brain Cancer Cure (ABC2) as President and CEO October 19, 2005 –- Tisch Family Gives $10 Million for Cancer Research at Duke October 19, 2005 –- Genentech and ABC2 Announce Second Brain Cancer Collaboration September 6, 2005 -- 2005 Brain Trust Awards Announced August 1, 2005 -- Letter to Family and Friends - Summary of Activities April 22, 2005 -- 2005 Project Awards Announced January 11, 2005 -- (Video) ABC2 Chairman Steve Case made a presentation to the January 11, 2005 JPMorgan Healthcare Conference in San Francisco. To view a portion of his presentation, click here for a Quicktime version, click here for a Windows Media Player version. Press Releases April 19, 2005 -- Four Leading Brain Philanthropies Announce Pioneering Collaboration – the Brain Trust Sept. 27, 2004 -- CombinatoRx and Accelerate Brain Cancer Cure (ABC2) Initiate Brain Cancer Collaboration — Partnership Speeds Search for Brain Cancer Cure May 18, 2004 -- Accelerate Brain Cancer Cure (ABC2) and Pediatric Brain Tumor Foundation Join Forces to Boost Research Funding at St. Jude Children's Research Hospital October 28, 2003 -- Accelerate Brain Cancer Cure (ABC2) names Young Investigator Awards June 4, 2003 -- Accelerate Brain Cancer Cure (ABC2) Foundation Comments on Genentech's Brain Cancer Trial Results Presented at ASCO May 8, 2003 -- Genentech and ABC2 Agree to Collaborate on Brain Cancer Clinical Trial April 2, 2003 -- ABC2, CaP CURE and Ingenuity Systems Kick Off Program to Identify Novel Uses for Existing Cancer Drugs March 5, 2003 -- Neuro-Oncology Fellowship Granted to UCSF by ABC2 April 8, 2002 -- Duke Comprehensive Cancer Center and ABC2 Collaborate to Accelerate Testing of New Brain Cancer Drugs February 25, 2002 -- Genentech to Collaborate with ABC2 for Brain Cancer Research - Biotech Company and Non-Profit Foundation Join Forces About ABC2 ABC2 was founded May 2001 by Dan and Steve Case and their families, along with leading scientists and entrepreneurs. In order to accelerate progress in what has been an underserved field of research, ABC2 provides researchers from all backgrounds with the support they need to make critical breakthroughs in brain cancer research. ABC2 aims to raise awareness about brain cancer and help mobilize critical scientific research through research grants and partnerships. # # #